CSL Limited

ASX:CSL.AX

Location

Market Cap

USD 75.68 B

Share Price

USD 156.33

Avg Daily Volume

902,529

Change (1 day)

0.91%

Change (1 year)

-19.21%

Change (YTD)

-10.30%

CSL Limited Common Stock Issued for the year ending June 30, 2024: USD 40.00 M

CSL Limited Common Stock Issued is USD 40.00 M for the year ending June 30, 2024, a 17.65% change year over year. Common stock issued is cash received from issuing new shares of the company’s common stock.
  • CSL Limited Common Stock Issued for the year ending June 30, 2023 was USD 34.00 M, a -99.32% change year over year.
  • CSL Limited Common Stock Issued for the year ending June 30, 2022 was USD 4.99 B, a 11,680.55% change year over year.
  • CSL Limited Common Stock Issued for the year ending June 30, 2021 was USD 42.34 M, a 45.50% change year over year.
  • CSL Limited Common Stock Issued for the year ending June 30, 2020 was USD 29.10 M, a 30.91% change year over year.
Key data
Date Common Stock Issued Common Stock Repurchased Free Cash Flow Operating Cash Flow
Market news
Loading...
ASX: CSL.AX

CSL Limited

CEO Dr. Paul F. McKenzie Ph.D.
IPO Date June 1, 1994
Location Australia
Headquarters 45 Poplar Road
Employees 32,698
Sector 🏥 Health Care
Industries
Description

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.

Similar companies

ILMN

Illumina, Inc.

USD 90.26

0.88%

RVTY

Revvity, Inc.

USD 94.41

0.27%

SYNGENE.NS

Syngene International Limited

USD 7.28

0.61%

002317.SZ

Guangdong Zhongsheng Pharmaceutical Co., Ltd.

USD 2.05

-1.99%

NOVO-B.CO

Novo Nordisk A/S

USD 75.07

1.29%

ABBV

AbbVie Inc.

USD 185.49

0.01%

RO.SW

Roche Holding AG

USD 338.56

1.02%

ABT

Abbott Laboratories

USD 132.41

0.10%

NOVN.SW

Novartis AG

USD 116.54

0.69%

AZN.L

AstraZeneca PLC

USD 142.38

0.60%

MRK

Merck & Co., Inc.

USD 79.29

1.29%

AMGN

Amgen Inc.

USD 289.63

-0.14%

BSX

Boston Scientific Corporation

USD 101.37

-0.35%

TMO

Thermo Fisher Scientific Inc.

USD 392.56

0.59%

PFE

Pfizer Inc.

USD 23.88

-0.50%

GILD

Gilead Sciences, Inc.

USD 108.00

0.00%

SAN.PA

Sanofi

USD 95.53

0.50%

VRTX

Vertex Pharmaceuticals Incorporated

USD 448.40

1.45%

BMY

Bristol-Myers Squibb Company

USD 46.84

-0.83%

REL.L

RELX Plc

USD 52.74

0.77%

4519.T

Chugai Pharmaceutical Co., Ltd.

USD 50.10

0.95%

GSK.L

GSK plc

USD 19.35

-0.49%

SHL.DE

Siemens Healthineers AG

USD 52.76

0.92%

REGN

Regeneron Pharmaceuticals, Inc.

USD 513.58

0.93%

MRK.DE

MERCK Kommanditgesellschaft auf Aktien

USD 125.22

-0.56%

207940.KS

Samsung Biologics Co.,Ltd.

USD 742.71

2.97%

BDX

Becton, Dickinson and Company

USD 168.59

-0.79%

600276.SS

Jiangsu Hengrui Medicine Co., Ltd.

USD 7.17

-0.44%

4502.T

Takeda Pharmaceutical Company Limited

USD 29.64

0.18%

ALNY

Alnylam Pharmaceuticals, Inc.

USD 312.32

1.17%

RGC

Regencell Bioscience Holdings Limited

USD 63.35

-18.78%

UCB.BR

UCB SA

USD 181.20

1.74%

A

Agilent Technologies, Inc.

USD 115.52

-0.49%

GEHC

GE HealthCare Technologies Inc.

USD 71.89

1.05%

BAYN.DE

Bayer AG

USD 30.95

-0.91%

IQV

IQVIA Holdings Inc.

USD 154.61

0.33%

068270.KS

Celltrion, Inc.

USD 118.94

2.83%

2359.HK

WuXi AppTec Co., Ltd.

USD 9.34

0.31%

22UA.F

BioNTech SE

USD 103.27

-1.03%

NTRA

Natera, Inc.

USD 170.98

2.05%

LH

Laboratory Corporation of America Holdings

USD 261.39

0.75%

3692.HK

Hansoh Pharmaceutical Group Company Limited

USD 3.54

0.04%

RPRX

Royalty Pharma plc

USD 34.91

1.01%

INSM

Insmed Incorporated

USD 99.46

-0.82%

BIIB

Biogen Inc.

USD 126.54

-0.02%

4503.T

Astellas Pharma Inc.

USD 9.35

0.21%

BIM.PA

bioMérieux S.A.

USD 136.66

0.21%

1801.HK

Innovent Biologics, Inc.

USD 9.71

-2.77%

BAX

Baxter International Inc.

USD 29.80

-0.40%

StockViz Staff

June 20, 2025

Any question? Send us an email